نتایج جستجو برای: recombinant human interferon alpha 2a rhifn α

تعداد نتایج: 2025614  

Journal: :Technology in cancer research & treatment 2002
Loree C Heller Stephanie F Ingram M Lee Lucas Richard A Gilbert Richard Heller

Interferon alpha may be used as a single agent therapy for metastatic malignant melanoma or as an adjuvant to chemotherapy. Delivery of interferon alpha by gene therapy offers an alternative to recombinant protein therapy. Electrically mediated delivery enhances plasmid expression in a number of tissues, for instance skin, liver, muscle and tumors including melanomas. Here we compare the effect...

قوتی, شاهرخ, میرحسینی, ضیاءالدین, پزشکیان, زهرا,

Background and purpose: Interferon beta-1b recombinant protein is used for reducing the relapse rate and treatment in patients with Multiple sclerosis (MS). In this study, phylogenetic and in silico analysis of interferon beta-1b were conducted by servers and bioinformatics tools to predict its structural potential. Materials and methods: Physiological and physico-chemical characteristics of...

ژورنال: Iranian Biomedical Journal 2016
Ilghari, Dariush, Kamyab, Ahmad Reza , Karimi Arzenani, Mohsen, Khamesipour, Ali, Mamnoon, Babak, Naserpour Farivar, Taghi,

Background: Existence of bacterial host cell DNA contamination in biopharmaceutical products is a potential risk factor for patients receiving these drugs. Hence, the quantity of contamination must be controlled under the regulatory standards. Although different methods such as hybridization assays have been employed to determine DNA impurities, these methods are labor, intensive and rather exp...

Journal: :The British journal of ophthalmology 2003
I Kötter M Zierhut A K Eckstein R Vonthein T Ness I Günaydin B Grimbacher S Blaschke W Meyer-Riemann H H Peter N Stübiger

BACKGROUND Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20-50% of the involved eyes within 5 years. The efficacy of interferon alfa-2a was studied in patients with sight threatening posterior uveitis or retinal vasc...

Journal: :The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2006
Necati Yenice Ozgür Mehtap Mübeccel Gümrah Nurten Arican

BACKGROUND/AIMS We aimed to compare viral responses to pegylated interferon 2a plus ribavirin with pegylated interferon alpha 2b plus ribavirin. METHODS Patients with the following characteristics were included: anti HCV(+); normal and/or elevated serum transaminase levels; positive HCV RNA by quantitative PCR; and at least stage 1 fibrosis according to Knodell Scoring System on liver biopsy....

2003
I Kötter M Zierhut A K Eckstein R Vonthein T Ness I Günaydin B Grimbacher Peter N Stübiger

Background: Behçet’s disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy of interferon alfa-2a was studied in patients with sight threatening posterior uveitis or retinal vas...

2017
Baiba Kurena Elisabeth Müller Panagiotis F. Christopoulos Ingvild Bjellmo Johnsen Branislava Stankovic Inger Øynebråten Alexandre Corthay Anna Zajakina

Cytokine gene delivery by viral vectors is a promising novel strategy for cancer immunotherapy. Semliki Forest virus (SFV) has many advantages as a delivery vector, including the ability to (i) induce p53-independent killing of tumor cells via apoptosis, (ii) elicit a type-I interferon (IFN) response, and (iii) express high levels of the transgene. SFV vectors encoding cytokines such as interle...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید